Try our Advanced Search for more refined results

RANBAXY LABORATORIES, LTD et al v. BURWELL et al

  1. March 11, 2015

    FDA Beats Ranbaxy Suit Despite 'Serious' Approval Errors

    The U.S. Food and Drug Administration acted within its authority when it stripped Ranbaxy Laboratories Ltd. of tentative approvals for two generics, but the agency also made "serious errors" by granting those approvals in the first place, according to a D.C. federal court ruling unsealed Wednesday.

  2. January 26, 2015

    FDA Backs Teva's Generic Nexium In Blow To Ranbaxy

    The U.S. Food and Drug Administration on Monday approved Teva Pharmaceutical Industries Ltd.'s generic version of AstraZeneca PLC's blockbuster heartburn drug Nexium, prompting an immediate response in D.C. federal court by Ranbaxy Laboratories Ltd., which originally had rights to the lucrative copycat.

  3. November 20, 2014

    Judge Scolds Kirkland & Ellis Attys In Ranbaxy-FDA Row

    A D.C. federal judge on Thursday rebuked Kirkland & Ellis LLP attorneys for allegedly withholding information from the court and opposing counsel, an unusual turn in a fast-moving fight between Ranbaxy Laboratories Ltd. and the U.S. Food and Drug Administration.

  4. November 17, 2014

    Ranbaxy Sues FDA Over Nixed Approvals Of Generics

    Ranbaxy Laboratories Ltd. sued the U.S. Food and Drug Administration in D.C. federal court on Friday over recently revoked tentative approvals for generic versions of AstraZeneca PLC's Nexium and Genentech Inc.'s Valcyte, saying the agency exceeded its authority and ignored federal law.